Wednesday, March 21, 2012: 2:30 p.m.-4 p.m.
Session Type: Oral Session
1.5 CE hours
Learning Objectives:
Discuss the effect of antimicrobial agents on plaque and gingivitis
Chairs:
T.A. LISANTE
and
C. GALINDO-LARTIGUE
In Vivo Antimicrobial Efficacy of Stannous Fluoride
M. ZSISKA1, B.W. PETERSON2, J.C. BUISSON1, D.J. WHITE1, and A.A. BAIG1, 1Procter & Gamble Company, Mason, OH, 2University Medical Center Greninger, Groningen, Netherlands
Antiplaque/Antigingivitis Efficacy of an Alcohol-Free Essential Oil Containing Mouthrinse
P. AMINI1, R.M. COSTA2, H. SHANG3, J. QAQISH4, J. GALLOB5, and M.W. ARAUJO2, 1BioSci Research, Las Vegas, NV, 2Oral Healthcare R&D, Johnson & Johnson Consumer Companies Inc, Morris Plains, NJ, 3Global Biometrics and Clinical Data System R&D, Johnson & Johnson Consumer Companies Inc, Shanghai, China, 4Biosci Research Canada, Ltd, Mississauga, ON, Canada, 5BioSci Research America, Inc, Las Vegas, NV